Chlorine in PDB 2ize: Apostreptavidin pH 3.08 I222 Complex
Protein crystallography data
The structure of Apostreptavidin pH 3.08 I222 Complex, PDB code: 2ize
was solved by
B.A.Katz,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
7.50 /
1.57
|
Space group
|
I 2 2 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
94.960,
105.360,
47.760,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.6 /
25.2
|
Other elements in 2ize:
The structure of Apostreptavidin pH 3.08 I222 Complex also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Apostreptavidin pH 3.08 I222 Complex
(pdb code 2ize). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the
Apostreptavidin pH 3.08 I222 Complex, PDB code: 2ize:
Jump to Chlorine binding site number:
1;
2;
Chlorine binding site 1 out
of 2 in 2ize
Go back to
Chlorine Binding Sites List in 2ize
Chlorine binding site 1 out
of 2 in the Apostreptavidin pH 3.08 I222 Complex
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Apostreptavidin pH 3.08 I222 Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl1464
b:91.2
occ:0.95
|
NA
|
B:NA403
|
0.7
|
67.6
|
1.0
|
HH
|
B:TYR43
|
1.8
|
18.8
|
1.0
|
HG
|
B:SER27
|
2.3
|
14.3
|
1.0
|
HD21
|
B:ASN23
|
2.5
|
16.0
|
1.0
|
OH
|
B:TYR43
|
2.8
|
21.1
|
1.0
|
HE1
|
B:TYR43
|
2.8
|
15.4
|
1.0
|
H1
|
B:HOH402
|
2.9
|
52.3
|
1.0
|
HZ2
|
B:TRP92
|
3.2
|
8.9
|
1.0
|
HD11
|
B:LEU25
|
3.2
|
26.0
|
1.0
|
OG
|
B:SER27
|
3.3
|
14.0
|
1.0
|
ND2
|
B:ASN23
|
3.4
|
15.0
|
1.0
|
HB2
|
B:SER27
|
3.4
|
11.2
|
1.0
|
CE1
|
B:TYR43
|
3.5
|
16.0
|
1.0
|
CZ
|
B:TYR43
|
3.5
|
16.6
|
1.0
|
HD22
|
B:ASN23
|
3.6
|
14.3
|
1.0
|
OG
|
B:SER45
|
3.7
|
32.5
|
1.0
|
CB
|
B:SER27
|
3.7
|
10.4
|
1.0
|
HB3
|
B:SER27
|
3.8
|
9.2
|
1.0
|
OD2
|
B:ASP128
|
3.8
|
13.2
|
1.0
|
O
|
B:HOH402
|
3.8
|
54.0
|
1.0
|
HG21
|
B:VAL47
|
3.9
|
35.1
|
1.0
|
H2
|
B:HOH402
|
4.1
|
51.5
|
1.0
|
HA
|
B:SER45
|
4.1
|
31.5
|
1.0
|
CD1
|
B:LEU25
|
4.3
|
27.2
|
1.0
|
H
|
B:ALA46
|
4.3
|
32.9
|
1.0
|
CZ2
|
B:TRP92
|
4.3
|
9.3
|
1.0
|
HB2
|
B:LEU25
|
4.3
|
21.1
|
1.0
|
HG
|
B:SER45
|
4.4
|
31.3
|
1.0
|
HD12
|
B:LEU25
|
4.4
|
26.3
|
1.0
|
HE1
|
B:TRP92
|
4.4
|
8.1
|
1.0
|
CG
|
B:ASN23
|
4.5
|
16.2
|
1.0
|
HB2
|
B:SER45
|
4.5
|
33.0
|
1.0
|
CB
|
B:SER45
|
4.5
|
33.2
|
1.0
|
CG
|
B:ASP128
|
4.7
|
16.1
|
1.0
|
HZ
|
B:PHE130
|
4.7
|
10.5
|
1.0
|
OD1
|
B:ASN23
|
4.7
|
18.2
|
1.0
|
CG2
|
B:VAL47
|
4.7
|
34.3
|
1.0
|
HD13
|
B:LEU25
|
4.7
|
25.8
|
1.0
|
HG23
|
B:VAL47
|
4.8
|
34.4
|
1.0
|
H
|
B:VAL47
|
4.8
|
32.9
|
1.0
|
CE2
|
B:TYR43
|
4.8
|
13.5
|
1.0
|
CD1
|
B:TYR43
|
4.9
|
14.2
|
1.0
|
CA
|
B:SER45
|
4.9
|
30.4
|
1.0
|
HH2
|
B:TRP79
|
4.9
|
20.0
|
1.0
|
O
|
B:HOH507
|
4.9
|
42.9
|
1.0
|
HG22
|
B:VAL47
|
5.0
|
34.6
|
1.0
|
|
Chlorine binding site 2 out
of 2 in 2ize
Go back to
Chlorine Binding Sites List in 2ize
Chlorine binding site 2 out
of 2 in the Apostreptavidin pH 3.08 I222 Complex
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Apostreptavidin pH 3.08 I222 Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Cl1459
b:0.8
occ:0.51
|
HN2
|
D:NH4508
|
0.4
|
59.5
|
1.0
|
HN4
|
D:NH4508
|
0.4
|
59.8
|
1.0
|
N
|
D:NH4508
|
0.9
|
59.5
|
1.0
|
HN1
|
D:NH4508
|
1.4
|
59.9
|
1.0
|
HN3
|
D:NH4508
|
1.5
|
59.3
|
1.0
|
HH
|
D:TYR43
|
2.4
|
18.8
|
1.0
|
HZ2
|
D:TRP92
|
2.9
|
10.9
|
1.0
|
HD13
|
D:LEU25
|
2.9
|
42.1
|
1.0
|
OD2
|
D:ASP128
|
3.0
|
22.2
|
1.0
|
HD22
|
D:ASN23
|
3.2
|
24.7
|
1.0
|
OH
|
D:TYR43
|
3.2
|
20.9
|
1.0
|
HD21
|
D:ASN23
|
3.4
|
25.2
|
1.0
|
HE1
|
D:TRP92
|
3.5
|
10.1
|
1.0
|
ND2
|
D:ASN23
|
3.6
|
25.8
|
1.0
|
HG
|
D:SER27
|
3.7
|
25.8
|
1.0
|
HD12
|
D:LEU25
|
3.7
|
41.7
|
1.0
|
CG
|
D:ASP128
|
3.8
|
20.0
|
1.0
|
CD1
|
D:LEU25
|
3.8
|
41.9
|
1.0
|
CZ2
|
D:TRP92
|
3.8
|
11.6
|
1.0
|
OD1
|
D:ASP128
|
3.9
|
31.5
|
1.0
|
O
|
D:HOH400
|
4.1
|
34.6
|
1.0
|
HD11
|
D:LEU25
|
4.3
|
42.3
|
1.0
|
NE1
|
D:TRP92
|
4.3
|
8.0
|
1.0
|
HE1
|
D:TYR43
|
4.3
|
13.3
|
1.0
|
CZ
|
D:TYR43
|
4.3
|
15.3
|
1.0
|
CE2
|
D:TRP92
|
4.3
|
8.3
|
1.0
|
H1
|
D:HOH400
|
4.3
|
34.0
|
1.0
|
HZ
|
D:PHE130
|
4.5
|
14.6
|
1.0
|
H2
|
D:HOH400
|
4.5
|
33.5
|
1.0
|
HG23
|
D:VAL47
|
4.5
|
62.4
|
1.0
|
OG
|
D:SER27
|
4.6
|
24.0
|
1.0
|
HE1
|
D:TRP108
|
4.6
|
11.3
|
1.0
|
HB2
|
D:SER27
|
4.7
|
24.2
|
1.0
|
CE1
|
D:TYR43
|
4.7
|
14.6
|
1.0
|
NE1
|
D:TRP108
|
4.7
|
12.3
|
1.0
|
HG22
|
D:THR90
|
4.9
|
6.7
|
1.0
|
HG22
|
D:VAL47
|
4.9
|
62.3
|
1.0
|
CG
|
D:ASN23
|
4.9
|
22.4
|
1.0
|
CH2
|
D:TRP92
|
4.9
|
8.6
|
1.0
|
HG21
|
D:VAL47
|
4.9
|
62.1
|
1.0
|
HG
|
D:LEU25
|
4.9
|
41.3
|
1.0
|
CE2
|
D:TRP108
|
5.0
|
9.2
|
1.0
|
CG
|
D:LEU25
|
5.0
|
40.9
|
1.0
|
|
Reference:
B.A.Katz,
B.A.Katz.
N/A N/A.
ISSN: ISSN 0022-2836
PubMed: 9405158
DOI: 10.1006/JMBI.1997.1444
Page generated: Sat Jul 20 08:35:14 2024
|